Shared Metabolic Profile of Caffeine in Parkinsonian Disorders

OBJECTIVE: The objective of this study was to determine comprehensive metabolic changes of caffeine in the serum of patients with parkinsonian disorders including Parkinson's disease (PD), progressive supranuclear palsy (PSP), and multiple system atrophy (MSA) and to compare this with healthy c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mov Disord
Autors principals: Takeshige‐Amano, Haruka, Saiki, Shinji, Fujimaki, Motoki, Ueno, Shin‐Ichi, Li, Yuanzhe, Hatano, Taku, Ishikawa, Kei‐Ichi, Oji, Yutaka, Mori, Akio, Okuzumi, Ayami, Tsunemi, Taiji, Daida, Kensuke, Ishiguro, Yuta, Imamichi, Yoko, Nanmo, Hisayoshi, Nojiri, Shuko, Funayama, Manabu, Hattori, Nobutaka
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2020
Matèries:
Regular Issue Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7496239/
https://ncbi.nlm.nih.gov/pubmed/32357260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.28068
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars